OncoDaily Newsletter

Subscribe to our newsletter

Subscribe

Could Targeting MEK Help T Cells Fight Cancer for Longer?

What Happens When One of Oncology’s Most Elusive Targets Finally Becomes Treatable? - CancerWorld

David Fajgenbaum: Emerging Link Between GLP-1 Drugs and Cancer Outcomes

Can Sparkling Drinks Cause Cancer? What Science Says About Minerals, Sweeteners, Acids, and Additives

Bill Gates Highlights Rwanda's Innovation-Driven Future

Oncology News, Insights, Stories by OncoDaily

Ian Tannock
OncoDaily Magazine

The Courage to Ask Better Questions - The Friendly Doctor Ian Tannock

FDA Daraxonrasib
Gastrointestinal Oncology

FDA Accepts Daraxonrasib NDA for Review in Previously Treated Metastatic Pancreatic Cancer

Tedros Adhanom Ghebreyesus
Voices

Tedros Adhanom Ghebreyesus: Ghana Strengthens Its Commitment to Health for All

FDA Grants Full Approval to Selpercatinib for RET Fusion–Positive Advanced Solid Tumors

Lisa Faulkner and Breast Cancer : Diagnosis, Surgery, and What She Revealed

Dario Trapani: Rethinking Cytoprotection in Modern Oncology

Enrique Grande: RAMPART Delivers a Critical Reality Check for Adjuvant Immunotherapy in RCC

Inside KCRS26 with Yüksel Ürün

Lived Experience Advocacy Hub Research Opportunity: Global Survey on Survivorship

10 Must-Read Posts on Cellular Immunotherapy This Week

Voices
Naveen Pemmaraju

Naveen Pemmaraju Speaks on 'Personalizing Care Across The MPN Spectrum' at LL&M Great Debates

Antonio Sommariva: International Collaboration At IOV Castelfranco Veneto HIPEC Meeting

Anjali Sibley: 3 Major Principles to Help Strategically Navigate the Cancer Journey

Becca Heist: Every Step Brings Hope to Patients with Cancer

Janice Cowden: Ensuring Patients Have Transparent Information Is as Important as Developing the Next Breakthrough Therapy

Asem Mansour: Empowering Patients to Participate in Care Decisions to Achieve Better Outcomes

SABCS 2026 Male Breast Cancer Advocate Scholarship

FDA Approvals
Subcutaneous Isatuximab Multiple Myeloma

FDA Approved Subcutaneous Isatuximab: Advancing Anti-CD38 Therapy Delivery in Multiple Myeloma

FDA Approves Belzutifan Plus Pembrolizumab for Adjuvant RCC

FDA Approved Decnupaz, the First ADC for Adults With BPDCN

FDA Approves FoundationOne CDx as Companion Diagnostic for TEPMETKO in METex14 NSCLC

FDA approved Atezolizumab for adjuvant treatment of MDR–positive MIBC

FDA Grants Approval for Oral Decitabine/Cedazuridine With Venetoclax in Newly Diagnosed AML

FDA Greenlit New Pancreatic Cancer Drug Daraxonrasib For Expanded Access

OncoDaily 100
100 influential survivors

100 Influential Cancer Survivors on Social Media: 2026 Edition

100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2025

The 100 Most Influential CEOs in Oncology in 2025 (Full List)

The 100 Most Influential People in Oncology in 2025 (Full List)

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2025

100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2024

Top 100 Xfluencers in Lung Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024

Celebrities and Cancer

OncoCalendar

ASCO GI Cancers Symposium 2027

American Society of Clinical Oncology (ASCO)

21 Jan
ASCO GI Cancers Symposium

ISCO 2026 Fall Clinical Meeting

Idaho Society of Clinical Oncology (ISCO)

13 Nov
ISCO 2026

2026 NNECOS Annual Meeting and Palliative Care Symposium

Northern New England Clinical Oncology Society (NNECOS)

06 Nov
NNECOS Annual Meeting

CGC 2026 Annual Meeting

Cancer Genomics Consortium (CGC)

01 Aug
CGC 2026

Mammo 2026: Global Breast Cancer Virtual Congress

OncoDaily

08 Oct
Mammo 2026

Immune-oncology
Can ctDNA Predict Both Benefit and Toxicity From Immunotherapy?

Can ctDNA Predict Both Benefit and Toxicity From Immunotherapy?

Primary Resistance to Atezolizumab–Bevacizumab in Hepatocellular Carcinoma

Tumor Microenvironment: Why It Matters for Cancer Immunotherapy

RICE Study: Can Immune Checkpoint Inhibitors Be Used Again After Progression?

KEYNOTE-C93: Pembrolizumab May Replace Chemotherapy in dMMR Endometrial Cancer

NK-Cell Immunotherapy: The Next Frontier in Cancer Treatment

ChemRNA: A New Generation of Simplified RNA Vaccines for Cancer Immunotherapy

Gastrointestinal-Oncology
CLDN18.2 CLARITY-Gastric01

CLARITY-Gastric01: Sonesitatug Vedotin Improves Overall Survival in 2L+ CLDN18.2-Positive Advanced Gastric/GEJ Cancers

Myriam Chalabi: A New Treatment Window for MSS Colon Cancer

FDA Accepts Daraxonrasib NDA for Review in Previously Treated Metastatic Pancreatic Cancer

LUCERNA Phase 3: Zolbetuximab, Pembrolizumab, and Chemotherapy in CLDN18.2/PD-L1–Positive Gastric/GEJ Cancer

ASCOLT Translational Study and Meta-analysis: Adjuvant Aspirin in Molecularly Selected Colorectal Cancer

Targeting the Primary Tumor in Metastatic Pancreatic Cancer 2026

COMPETE Trial: [177Lu]Lu-Edotreotide Prolongs PFS vs Everolimus in Advanced GEP NETs

Breast-Oncology
RxPONDER

RxPONDER Analysis: Ovarian Reserve May Refine Chemotherapy Decisions in HR-Positive Breast Cancer

Pregnancy and Recent Childbirth Do Not Independently Worsen Outcomes in Young Women With Early Breast Cancer

BRCA2 Pathogenic Variants May Identify a Higher-Risk Group in First-Line ER+ Metastatic Breast Cancer

CDK2 Inhibition in CDK4/6 - Resistant Breast Cancer: A New Escape Route Under Study

Gedatolisib Enters ER+ Breast Cancer Care, But the Real Question Is How to Use It

The CDK4/6 Inhibitor Story Is Entering Its Next Chapter in Breast Cancer

High-Risk Node-Negative HR+/HER2− Early Breast Cancer May Carry Recurrence Risk Similar to N1 Disease

Lung-Oncology
Icotinib

Adjuvant Icotinib Linked to Better DFS in Resected Stage IA EGFR-Mutant Lung Adenocarcinoma

Izalontamab Brengitecan Shows Encouraging Activity in Relapsed ES-SCLC

AdvanTIG-302: Ociperlimab Plus Tislelizumab Does Not Improve Survival in PD-L1–High NSCLC

FDA Approves Zidesamtinib for Previously Treated ROS1-Positive NSCLC

Brain-Only Progression in ES-SCLC: When the Brain Progresses, the Systemic Backbone May Still Matter

EGFR Exon 20 and HER2-Deregulated NSCLC: The Rare Lung Cancer Subtypes Moving Into a New Therapeutic Era

EMBER-Lung: A Simple EMR Nudge Nearly Doubled Molecular Testing in Early-Stage NSCLC

Oncology Tech
Personalis

Tempus AI to Acquire Personalis in $1.5 Billion Deal, Deepening Its Foothold in Cancer Monitoring

FDA approves GSK's Jideytro for previously treated ROS1-positive NSCLC, the company's first lung cancer clearance

Third Time at the Table: Why Replimune's RP1 Deserves a Real Hearing in Post-PD-1 Melanoma

James Hadfield: Emerging Technologies Aim to Democratize Ultra-Sensitive MRD Testing

The radiopharmaceutical land grab — and the isotope bottleneck no one's pricing in

The Thirteen-Minute Infusion: What Sarclisa's Wearable Injector Signals for Cancer Care

Kalshi Launches Sportsbook-Style Markets on Drug Trials and FDA Decisions

Hematology
Leukemia Diagnosis Leukemia symptoms

Leukemia Diagnosis: Every Step From First Symptoms to Treatment and Beyond

Prognostic Scores and Risk Stratification in Myeloproliferative Neoplasms (MPN): 2026 Updates

Chronic Myelomonocytic Leukemia (CMML): Beyond the Overlap, Toward the Bigger Picture

Non-Hodgkin Lymphoma (NHL): A Practical Biological Map and Integrative Overview

ENDURANCE Trial: 2 Years of Lenalidomide Maintenance Matches Continuous Therapy in Standard-Risk Multiple Myeloma

Peripheral T-Cell Lymphomas (PTCL): Another Evolving Lymphoma Story

Europe Opens the Door to Epcoritamab-R² in 2L Follicular Lymphoma: A New Standard?

Radiotherapy
90Y-SIRT

Beyond Mean Dose: Rethinking 90Y-SIRT in HCC

Optimizing Rectal Preparation for Safer Prostate SBRT

Mapping Palliative Radiotherapy Access Across Canada

Early Lung Cancer With ILD: SABR and Surgery Remain Curative Options

MR-Guided Radiotherapy Brings Pain Relief in Metastatic Pancreatic Cancer

GammaTile Redefines Postoperative Radiation for Brain Metastases: Lessons from the Phase III ROADS Trial

Life After Anal Cancer: The Hidden Burden of Chemoradiotherapy

OncoDaily TV
World Health Voices

Is US Still a WHO Member? World Health Voices Interview with Prof. Lawrence O. Gostin

Antonio Jimenez (2)

Antonio Jimenez Jimenez: A Powerful Reminder of Why NMDP Work Matters

Can Research Funding Save More Lives: Dr. Kimberly Sabelko Explains

Can Research Funding Save More Lives: Dr. Kimberly Sabelko Explains

lisa-thompson-smith-reimbursemement

The System Behind Access of New Cancer Drugs with Lisa Thompson Smith

Elas Sharon, Med News Week

Navigating the Intersection of Immunotherapy and Autoimmunity Dr. Elad Sharon

Rodrigo Sánchez-Bayona open doors

What Makes a Great Oncologist? Insights from Dr. Rodrigo Sánchez-Bayona

Daraxonrasib for Pancreatic Cancer: What’s Next?

Daraxonrasib for Pancreatic Cancer: What’s Next?

1000 doctors standing asco alan sandler

Why 1000 Doctors Gave This Cancer Drug A Standing Ovation?

Empowering Oncologists: Are Digital Literacy Tools Critically Important?

Empowering Oncologists: Are Digital Literacy Tools Critically Important?

ASCO

OncoDaily Highlights from ASCO 2026 Chicago, USA

Episode 17: Global Health Dialogues with Princess Dina and Eman Shannan

Episode 17: Global Health Dialogues with Princess Dina and Eman Shannan

Where You Live Shouldn't Dictate Your Cancer Survival: Dr. Benjamin Anderson

Where You Live Shouldn’t Dictate Your Cancer Survival: Dr. Benjamin Anderson

Not To Miss
Community Oncology Global Congress

Community Oncology Global Congress 2026: Bringing Cancer Care Closer to Where Patients Live

GC-OS 2026 to Bring the Global Cardio-Oncology Community to Williamsburg

3rd Symposium “Artificial Intelligence in Public Health Research”

2026 IBRI Global Forum on Science, Philanthropy, and Investment

15 Posts Not To Miss From Best of ASCO Africa 2026

Top Growing Medical Universities in Africa: 2026 Edition by BIGR

WHO Calls for Urgent Action as New Cancer Cases Are Projected to Nearly Double by 2050

OncoGrants
Prostate Cancer Research

Prostate Cancer Research Collaborative Seed Grant

Research Award

2026 LCRF + AstraZeneca Research Award: Improving SCLC Treatment

Long-term International Fellowship

Conquer Cancer Long-term International Fellowship 2027

CCLG Idea Grant 2026

Bone Cancer Research Trust + CCLG Idea Grant 2026: Advancing Ewing Sarcoma and Osteosarcoma Research

Young Investigator Award 2027

Conquer Cancer Young Investigator Award 2027

Clinical Accelerator Initiative 2026

Lustgarten Foundation Dr. Robert F. Vizza Clinical Accelerator Initiative 2026

Oncologist near me
Oncologist Near Me

Oncologist Near Me – Gregory Kalemkerian: Advancing Lung Cancer Care, Research, and Education
Oncologist Near Me

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership
Oncologist Near Me

Oncologist Near Me – Paolo Tarantino: Shaping the Future of Breast Cancer Treatment
Oncologist Near Me

Oncologist Near Me – Rana McKay: A Rising Force in Genitourinary Cancer Research and Care
Oncologist Near Me

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine
Oncologist Near Me

Oncologist Near Me – Yelena Janjigian: A Global Leader in Gastrointestinal Oncology
Oncologist Near Me

Oncologist Near Me – Bishal Gyawali: Challenging the Status Quo in Global Oncology
Oncologist Near Me

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology
Oncologist Near Me

Oncologist Near Me – Wafik S. El-Deiry: A Global Leader in Translational Oncology and Cancer Research
Oncologist Near Me

Oncologist Near Me – Enrique Soto: A Leader in Geriatric Oncology and Global Cancer Care

Cancer types
Non-Hodgkin Lymphoma NHL, DLBCL

Non-Hodgkin Lymphoma (NHL): A Practical Biological Map and Integrative Overview

Mantle Cell Lymphoma (MCL): Revealing the Biology Beneath the Mantle and Modern Therapeutic Frontiers

Burkitt Lymphoma: Among the Fastest Growing Yet Most Curable Human Cancers

Diffuse Large B-Cell Lymphoma (DLBCL): Molecular Heterogeneity and Progress in Therapy

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Current Perspectives on an Ultra-Rare Malignancy

Richter Transformation (RT): When Chronic Lymphocytic Leukemia Turns Aggressive

Acute Myeloid Leukemia (AML) in 2026: The Current Landscape and Future Perspectives

CancerWorld

Oncologists
Assia Konsoulova

Assia Konsoulova

Oncologists Location Sofia, Bulgaria
Kathleen Schmeler

Kathleen Schmeler

Oncologists Location Houston, USA
Onyinye Balogun

Onyinye Balogun

Oncologists Location New York, USA
Paolo Tarantino

Paolo Tarantino

Oncologists Location Boston, USA
Saro Armenian

Saro Armenian

Oncologists Location Duarte, USA
Piotr J. Wysocki

Piotr J. Wysocki

Oncologists Location Kraków, Poland
Sarkis Meterissian

Sarkis Meterissian

Oncologists Location Montreal, Canada
Petros Grivas

Petros Grivas

Oncologists Location Seattle, USA

Oncology Drugs
Ponsegromab: Mechanism, Clinical Trials, Presented Data, and Future Role in Cancer Cachexia

Ponsegromab: Mechanism, Clinical Trials, Presented Data, and Future Role in Cancer Cachexia

Sacituzumab Tirumotecan: What Patients Should Know About This Emerging Cancer Treatment

Sacituzumab Tirumotecan: Clinical Development, Mechanism, and Emerging Role in Modern Oncology

Lurbinectedin: What Patients Should Know

Lurbinectedin in Oncology: Mechanism, Clinical Data, Evolving Role, and Future Directions

Bemarituzumab: What Patients with Gastric Cancer Should Know

Bemarituzumab: Uses in Cancer, Side Effects, Dosages, Expectations and More

OncoDaily Magazine

New Paper Alert
Rodrigo Lastra del Prado

Rodrigo Lastra del Prado: Benefits of Empathetic Oncologist Patient Communication

ICRA trial

The ICRA trial: Paclitaxel Plus Tremelimumab Shows Activity After Platinum and PD-(L)1 Therapy in Metastatic Urothelial Cancer

Screening - OncoDaily

A Unified Framework for Pre-Screening and Screening Tools in Oncology Clinical Trials 2026

Cardiovascular Disease

Prevention And Management Of Cardiovascular Disease In Adults With Cancer: IC-OS And MASCC Clinical Practice Statement

EORTC–ESTRO

Endpoints in Metastases Directed Therapy for Oligometastatic Cancer A Review and Consensus by the EORTC–ESTRO OligoCare Consortium

MONTBLANC Trial

MONTBLANC Trial Recruitment Completed: Triple Immunotherapy in Advanced HCC

OncoDaily Medical Journal

Public Health

10.69690/ODMJ-002-0726-7335

From Evidence to Impact: Multilevel Strategies for Cancer Prevention in Europe
Reviews

Oncology Nursing

10.69690/ODMJ-011-0626-7610

Major oral hemorrhage after tongue cancer surgery: A case report
Case Reports & Case Series

Lung Cancer

10.69690/ODMJ-001-0626-7958

Evaluation of Intra-Fractional Target Position Variation during Deep Inspiration Breath-Hold (DIBH) Sessions in Lung Stereotactic Body Radiotherapy (SBRT)
Original Research

Hematology

10.69690/ODMJ-001-0526-7344

Analysis of Mortality Factors in the Pediatric Hemato-Oncology Department of the Children's Hospital of Rabat, 2022-2023
Original Research

Radiation Oncology

10.69690/ODMJ-011-0526-7409

An Independent Read-Only Verification and Risk-Management System to Maintain Radiotherapy Safety During Oncology Information System Failure
Case Reports & Case Series

Cancer Care

10.69690/ODMJ-001-0426-7451

Distinct differences in the tumour-resident microbiome between early- and late-onset colorectal cancer
Original Research

Hematology

10.69690/odmj-012-0426-7512

Frailty, infections, and bispecific antibodies in multiple myeloma: redefining supportive care in the era of T-cell redirection
Commentaries

Oncology Nursing

10.69690/ODMJ-002-0426-7359

Barriers and Facilitators of Oral Nutritional Supplement Adherence in Cancer: A Systematic Review
Reviews